| Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use E Schaafsma, B Zhang, M Schaafsma, CY Tong, L Zhang, C Cheng Breast Cancer Research 23, 1-11, 2021 | 41 | 2021 |
| Chr20q amplification defines a distinct molecular subtype of microsatellite stable colorectal cancer B Zhang, K Yao, E Zhou, L Zhang, C Cheng Cancer research 81 (8), 1977-1987, 2021 | 17 | 2021 |
| A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma E Zhou, B Zhang, K Zhu, E Schaafsma, RD Kumar, C Cheng Clinical and Translational Medicine 10 (8), 2020 | 10 | 2020 |
| Deep learning predicts EBV status in gastric cancer based on spatial patterns of lymphocyte infiltration B Zhang, K Yao, M Xu, J Wu, C Cheng Cancers 13 (23), 6002, 2021 | 7 | 2021 |
| TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs C Li, B Zhang, E Schaafsma, A Reuben, L Wang, MJ Turk, J Zhang, ... Cell Reports Medicine 4 (7), 2023 | 4 | 2023 |
| Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes K Yao, E Zhou, E Schaafsma, B Zhang, C Cheng Cancer Medicine 12 (5), 5590-5602, 2023 | 3 | 2023 |
| Immune infiltration difference between tumor and adjacent normal regions is prognostic for gastric cancer patients B Zhang, K Yao, C Cheng Clinical and translational discovery 2 (1), 2022 | 3 | 2022 |
| The ratio of intratumour to stromal infiltrating lymphocytes better predicts prognosis in breast cancer B Zhang, X Wang, C Cheng Clinical and Translational Medicine 13 (5), 2023 | 2 | 2023 |
| Binding peptide generation for MHC Class I proteins with deep reinforcement learning Z Chen, B Zhang, H Guo, P Emani, T Clancy, C Jiang, M Gerstein, X Ning, ... Bioinformatics 39 (2), btad055, 2023 | 2 | 2023 |
| A network-based integration for understanding racial disparity in prostate cancer B Zhang, K Yao, C Cheng Translational Oncology 17, 101327, 2022 | 2 | 2022 |
| Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer B Zhang, J Li, M Tang, C Cheng Cancers 15 (15), 3977, 2023 | 1 | 2023 |
| Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer K Yao, E Schaafsma, B Zhang, C Cheng PLOS Computational Biology 18 (3), e1009495, 2022 | 1 | 2022 |
| DeepCG: A cell graph model for predicting prognosis in lung adenocarcinoma B Zhang, C Li, J Wu, J Zhang, C Cheng International journal of cancer 154 (12), 2151-2161, 2024 | | 2024 |
| Sex-Based Differences in Melanoma Survival Improvement from 2004 to 2018 VR Shaw, A Hudock, B Zhang, C Amos, C Cheng Cancers 16 (7), 1308, 2024 | | 2024 |
| Racial and socioeconomic disparities in survival improvement of eight cancers V Shaw, B Zhang, M Tang, W Peng, C Amos, C Cheng BJC Reports 2 (1), 21, 2024 | | 2024 |
| TimiGP: Dissect the tumor immune microenvironment and its association with survival and immunotherapy response C Li, W Hong, B Zhang, E Schaafsma, A Reuben, J Zhang, C Cheng Cancer Research 83 (7_Supplement), 2080-2080, 2023 | | 2023 |
| Cancer patient stratification based on immune infiltration E Schaafsma, B Zhang, Y Zhao, C Cheng Elsevier, 2023 | | 2023 |
| TimiGP: inferring inter-cell functional interactions and clinical values in the tumor immune microenvironment through gene pairs C Li, B Zhang, E Schaafsma, A Reuben, J Zhang, C Cheng bioRxiv, 2022.11. 17.515465, 2022 | | 2022 |
